SoftBank: pay cuts do not offset investment flops - FT中文网
登录×
电子邮件/用户名
密码
记住我
请输入邮箱和密码进行绑定操作:
请输入手机号码,通过短信验证(目前仅支持中国大陆地区的手机号):
请您阅读我们的用户注册协议隐私权保护政策,点击下方按钮即视为您接受。
FT商学院

SoftBank: pay cuts do not offset investment flops

Founder Masayoshi Son has promised to play defence, slowing the pace of new investments and preserving cash

Founder Masayoshi Son is trying to turn round the fortunes of SoftBank following a historic loss for its Vision Fund unit. But moves to counteract falling profits and a dwindling share price are too little, too late. They include steep pay cuts for executives of the Japanese tech investment group.

The surprisingly steep reductions follow a record investment loss of ¥3.5tn ($27.5bn) at the Vision Fund unit for the year to March. Oddly, Son’s pay was unchanged at Y100mn ($785,000). Executives who suffered pay package shrinkage included chief financial officer Yoshimitsu Goto. His remuneration dropped 40 per cent compared with the previous year

SoftBank has a history of largesse. Simon Segars, the former chief executive of the company’s chip unit Arm, earned $9mn during the three months that he was a board director. Former chief operating officer Marcelo Claure, who left SoftBank earlier this year after months of frosty negotiations over pay, earned more than $14mn in the year before his departure. That put him on a par with former chief operating officer of Bank of America Thomas Montag.

SoftBank blamed the record loss at its first Vision Fund in the year to March on the tech sell-off in the US and China. But some prominent companies in which SoftBank is the largest shareholder have performed far worse than the market. Shares in South Korean ecommerce platform Coupang have plunged 72 per cent since it listed. The stock of Didi, a Chinese ride-hailing group, has fallen 75 per cent in the past year.

Such reversals call into question the strategy of SoftBank executives including Rajeev Misra, chief executive of SoftBank Investment Advisers, which oversees the firm’s Vision Funds.

SoftBank shares have halved since their 2021 peak. They trade below book value at less than half the group’s stated net asset value of $150bn.

Son has promised to play defence, slowing the pace of new investments and preserving cash. The question for investors should be whether it is worth holding shares in a business that is still paying executives highly to underperform the market.

版权声明:本文版权归FT中文网所有,未经允许任何单位或个人不得转载,复制或以任何其他方式使用本文全部或部分,侵权必究。

凯勒拉治疗学公司在生物技术领域创纪录的IPO中融资6.25亿美元

最新的生物科技公司首次公开募股创下历史新高。
19小时前

Rivian向大型汽车制造商推介软件合作

Rivian首席执行官表示,如果没有更好的软件,传统车企不可能维持其市场份额。

Mythos网络安全风波,预示AI将进入稀缺经济时代

随着前沿模型不断进化,谁能拿到这项技术,可能会变得至关重要。

日本医生警告:伊朗战争将威胁医疗物资供应

首相高市早苗下令释放手套储备,全亚洲忧虑加剧

特朗普能否将鲍威尔从美联储主席之位拉下马?

特朗普表示,如果他提名的继任者沃什在5月15日前未获确认,他将寻求解雇现任主席鲍威尔。

北约与欧盟就防务支出爆发“地盘之争”

这场争议的核心在于,欧盟资金是否应用于采购美国武器。
设置字号×
最小
较小
默认
较大
最大
分享×